Table 2.
Clinicopathological features of 118 cases of high-grade non-muscle invasive bladder cancer
| Variables | Number of cases (%) | |
|---|---|---|
| Sex | Male | 104 (88.1) |
| Female | 14 (11.9) | |
| Multiplicity | Absence | 51 (43.2) |
| Presence | 67 (56.8) | |
| Tumor size | Not recorded | 14 (11.9) |
| < 1.5 cm | 16 (13.6) | |
| 1.5 cm-3 cm | 48 (40.7) | |
| > 3 cm | 40 (33.9) | |
| pT stage | Ta | 17 (14.4) |
| T1 | 101 (85.6) | |
| Proportion of invasive component | ≤ 50 | 84 (71.2) |
| > 50 | 34 (28.8) | |
| Carcinoma in situ | Absence | 79 (66.9) |
| Presence | 39 (33.1) | |
| Lymphovascular invasion | Absence | 116 (98.3) |
| Presence | 2 (1.7) | |
| Muscularis propria | Not included | 34 (28.8) |
| Included | 83 (70.3) | |
| Not assessablea | 1 (0.8) | |
| Stage progression | Absence | 100 (84.7) |
| Presence | 18 (15.3) |
a
Not assessable: due to cautery artifact, fragmentation, or incorrect orientation of tumor tissues.